Einträge von Wirtz, Ralph M. auf dem Publikationsserver

Haas, Maximilian , Kriegmair, Maximilian C., Breyer, Johannes , Sikic, Danijel, Wezel, Felix, Roghmann, Florian, Brehmer, Mirco, Wirtz, Ralph M., Jarczyk, Jonas, Erben, Philipp, Bahlinger, Veronika, Goldschmidt, Franziska, Fechner, Guido, Chen, Jack, Paxinos, Ellen, Bates, Michael, Zengerling, Friedemann, Bolenz, Christian, Burger, Maximilian, Hartmann, Arndt und Eckstein, Markus (2024) Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC Monitor. BJU International.

Breyer, Johannes, Eckstein, Markus, Sikic, Danijel, Wezel, Felix, Roghmann, Florian, Brehmer, Mirco, Wirtz, Ralph M., Jarczyk, Jonas, Erben, Philipp, Bahlinger, Veronika, Goldschmidt, Franziska, Fechner, Guido, Chen, Jack, Paxinos, Ellen, Bates, Michael, Haas, Maximilian, Zengerling, Friedemann, Bolenz, Christian, Burger, Maximilian, Hartmann, Arndt, Kriegmair, Maximilian C. und BRIDGE Consortium e.V., . (2023) Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial). Scientific Reports 13 (1).

Bubb, Maria, Beyer, Anna-Sophia Lieselott, Dasgupta, Pooja , Kaemmerer, Daniel, Sänger, Jörg, Evert, Katja, Wirtz, Ralph M., Schulz, Stefan und Lupp, Amelie (2022) Assessment of G Protein-Coupled Oestrogen Receptor Expression in Normal and Neoplastic Human Tissues Using a Novel Rabbit Monoclonal Antibody. International Journal of Molecular Sciences 23 (9), S. 5191. Volltext nicht vorhanden.

Sikic, Danijel, Eckstein, Markus, Weyerer, Veronika, Kubon, Jennifer, Breyer, Johannes, Roghmann, Florian, Kunath, Frank, Keck, Bastian, Erben, Philipp, Hartmann, Arndt, Wirtz, Ralph M., Wullich, Bernd, Taubert, Helge und Wach, Sven (2022) High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancer. Urologic Oncology: Seminars and Original Investigations 40 (2), 63.e9-63.e18. Volltext nicht vorhanden.

Mayr, Roman, Eckstein, Markus, Wirtz, Ralph M., Santiago-Walker, Ademi, Baig, Mahadi, Sundaram, Ramesh, Carcione, Jenna Cody , Stoehr, Robert, Hartmann, Arndt, Bolenz, Christian, Burger, Maximilian, Otto, Wolfgang, Erben, Philipp und Breyer, Johannes (2022) Prognostic and Predictive Value of Fibroblast Growth Factor Receptor Alterations in High-grade Non–muscle-invasive Bladder Cancer Treated with and Without Bacillus Calmette-Guérin Immunotherapy. European Urology 81 (6), S. 606-614. Volltext nicht vorhanden.

Sikic, Danijel, Taubert, Helge , Wirtz, Ralph M., Breyer, Johannes, Eckstein, Markus, Weyerer, Veronika , Kubon, Jennifer, Erben, Philipp , Bolenz, Christian, Burger, Maximilian, Hartmann, Arndt, Wullich, Bernd, Wach, Sven und Keck, Bastian (2021) High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer. Life 11 (7), S. 642. Volltext nicht vorhanden.

Tully, Karl H., Jütte, Hendrik, Wirtz, Ralph M., Jarczyk, Jonas, Santiago-Walker, Ademi, Zengerling, Friedemann, Breyer, Johannes, Sikic, Danijel, Kriegmair, Maximilian C., von Hardenberg, Jost , Wullich, Bernd, Taubert, Helge, Weyerer, Veronika, Stoehr, Robert, Bolenz, Christian, Burger, Maximilian, Porubsky, Stefan , Hartmann, Arndt, Roghmann, Florian, Erben, Philipp und Eckstein, Markus (2021) Prognostic Role of FGFR Alterations and FGFR mRNA Expression in Metastatic Urothelial Cancer Undergoing Checkpoint Inhibitor Therapy. Urology 157, S. 93-101. Volltext nicht vorhanden.

Sikic, Danijel, Eckstein, Markus, Wirtz, Ralph M., Jarczyk, Jonas, Worst, Thomas S. , Porubsky, Stefan , Keck, Bastian, Kunath, Frank, Weyerer, Veronika, Breyer, Johannes , Otto, Wolfgang, Rinaldetti, Sebastien, Bolenz, Christian, Hartmann, Arndt, Wullich, Bernd und Erben, Philipp (2020) FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy. Journal of Clinical Medicine 9 (4), S. 994. Volltext nicht vorhanden.

Erben, Philipp, Sikic, Danijel, Wirtz, Ralph M., Martini, Thomas, Weis, Cleo-Aron, Breyer, Johannes, Otto, Wolfgang, Keck, Bastian, Hartmann, Arndt und Bolenz, Christian (2019) Analysis of the prognostic relevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladder. Virchows Archiv 474 (2), S. 209-217. Volltext nicht vorhanden.

Sikic, Danijel, Wirtz, Ralph M., Wach, Sven, Dyrskjøt, Lars , Erben, Philipp, Bolenz, Christian, Breyer, Johannes, Otto, Wolfgang, Hoadley, Katherine A. , Lerner, Seth P., Eckstein, Markus, Hartmann, Arndt und Keck, Bastian (2019) Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts. Translational Oncology 12 (4), S. 661-668. Volltext nicht vorhanden.

Eckstein, Markus, Erben, Philipp, Kriegmair, Maximilian C., Worst, Thomas S., Weiß, Cleo-Aron, Wirtz, Ralph M., Wach, Sven, Stoehr, Robert, Sikic, Danijel, Geppert, Carol I., Weyerer, Veronika, Bertz, Simone, Breyer, Johannes, Otto, Wolfgang, Keck, Bastian, Burger, Maximilian, Taubert, Helge, Weichert, Wilko, Wullich, Bernd, Bolenz, Christian, Hartmann, Arndt und Erlmeier, Franziska (2019) Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab. European Journal of Cancer 106, S. 234-243. Volltext nicht vorhanden.

Pfannstiel, Carolin, Strissel, Pamela L., Chiappinelli, Katherine B., Sikic, Danijel, Wach, Sven, Wirtz, Ralph M., Wullweber, Adrian, Taubert, Helge, Breyer, Johannes, Otto, Wolfgang, Worst, Thomas, Burger, Maximilian, Wullich, Bernd, Bolenz, Christian, Fuhrich, Nicole, Geppert, Carol I., Weyerer, Veronika, Stoehr, Robert, Bertz, Simone, Keck, Bastian, Erlmeier, Franziska, Erben, Philipp, Hartmann, Arndt, Strick, Reiner und Eckstein, Markus (2019) The Tumor Immune Microenvironment Drives a Prognostic Relevance That Correlates with Bladder Cancer Subtypes. Cancer Immunology Research 7 (6), S. 923-938. Volltext nicht vorhanden.

Worst, Thomas S., Weis, Cleo-Aron, Stöhr, Robert, Bertz, Simone, Eckstein, Markus, Otto, Wolfgang, Breyer, Johannes, Hartmann, Arndt, Bolenz, Christian, Wirtz, Ralph M. und Erben, Philipp (2018) CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making. Scientific Reports 8 (1). Volltext nicht vorhanden.

Breyer, Johannes, Wirtz, Ralph M., Erben, Philipp, Rinaldetti, Sebastien, Worst, Thomas S., Stoehr, Robert, Eckstein, Markus, Sikic, Danijel, Denzinger, Stefan, Burger, Maximilian, Hartmann, Arndt und Otto, Wolfgang (2018) FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer. BJU International 123 (1), S. 187-196. Volltext nicht vorhanden.

Breyer, Johannes, Wirtz, Ralph M., Erben, Philipp, Worst, Thomas S., Stoehr, Robert, Eckstein, Markus, Bertz, Simone, Sikic, Danijel, Denzinger, Stefan, Burger, Maximilian, Hartmann, Arndt, Otto, Wolfgang, Breyer, Johannes, Wirtz, Ralph M., Erben, Philipp, Worst, Thomas S., Stoehr, Robert, Eckstein, Markus, Sikic, Danijel, Burger, Maximilian, Hartmann, Arndt und Otto, Wolfgang (2018) High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder Carcinoma. Clinical Genitourinary Cancer 16 (4), 248-256.e2. Volltext nicht vorhanden.

Breyer, Johannes, Wirtz, Ralph M., Otto, Wolfgang, Erben, Philipp, Worst, Thomas S., Stoehr, Robert, Eckstein, Markus, Denzinger, Stefan, Burger, Maximilian und Hartmann, Arndt (2018) High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients. Cancer Immunology, Immunotherapy 67 (3), S. 403-412. Volltext nicht vorhanden.

Sikic, Danijel, Breyer, Johannes, Hartmann, Arndt, Burger, Maximilian, Erben, Philipp, Denzinger, Stefan, Eckstein, Markus, Stöhr, Robert, Wach, Sven, Wullich, Bernd, Keck, Bastian, Wirtz, Ralph M. und Otto, Wolfgang (2017) High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer. Translational Oncology 10 (3), S. 340-345. Volltext nicht vorhanden.

Breyer, Johannes, Wirtz, Ralph M., Otto, Wolfgang, Erben, Philipp, Kriegmair, Maximilian C., Stoehr, Robert, Eckstein, Markus, Eidt, Sebastian, Denzinger, Stefan, Burger, Maximilian und Hartmann, Arndt (2017) In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival. Virchows Archiv 470 (3), S. 267-274. Volltext nicht vorhanden.

Breyer, Johannes, Otto, Wolfgang, Wirtz, Ralph M., Wullich, Bernd, Keck, Bastian, Erben, Philipp, Kriegmair, Maximilian C. , Stoehr, Robert, Eckstein, Markus, Laible, Mark, Schlombs, Kornelia, Eidt, Sebastian, Denzinger, Stefan, Burger, Maximilian und Hartmann, Arndt (2016) ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ. Urologia Internationalis 98 (3), S. 282-289. Volltext nicht vorhanden.

Breyer, Johannes, Wirtz, Ralph M., Laible, Mark, Schlombs, Kornelia, Erben, Philipp, Kriegmair, Maximilian Christian, Stoehr, Robert, Eidt, Sebastian, Denzinger, Stefan, Burger, Maximilian, Hartmann, Arndt und Otto, Wolfgang (2016) ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC). Virchows Archiv 469 (5), S. 547-552. Volltext nicht vorhanden.